Multiple Myeloma: Inside the Issue of Cereblon E3 Ligase Modulators

Research To Practice | Oncology Videos · Feb 18, 2026 · 57m

Featuring perspectives from Dr Natalie S Callander and Dr Paul G Richardson, including the following topics:

Introduction: Clinical Trials We LOVE to Discuss (0:00)

Mechanism of Action of Cereblon E3 Ligase Modulators (CELMoDs) (8:42)

Available Efficacy Data with CELMoDs in the Management of Relapsed/Refractory Multiple Myeloma (MM) (15:59)

Extramedullary Disease (19:23)

Spectrum and Management of CELMoD-Associated Adverse Events (30:12)

Ongoing Phase II and III Trials Evaluating CELMoDs for MM (34:53)

CME information and select publications